Martin Shkreli Faces New Accusations Over High-Priced Drug

A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.

from NYT > Technology https://ift.tt/38JaGe7

Comments

Popular posts from this blog

Prof. M. Ramalinga Raju appointed as Vice Chancellor of JNTU Kakinada

APJAKTU Exam Registration opened - B.Tech (FT,PT) July 2021 (2019 and 2015 scheme)